Explore News By Topic


FDA approves first precision medicine for the treatment of cancers with certain genetic defects, including prostate cancer

On May 23, 2017, the field of precision medicine achieved a major milestone with the FDA’s first ever approval of a cancer therapy based entirely on a tumor’s unique characteristics and not where the tumor developed in the body.  In other words, while therapies to date have been approved for... Read More